Antibe Therapeutics Inc operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Antibe Therapeutics Inc with three other
miscellaneous service companies in North America:
Field Trip Health Ltd
sales of 960,895.00 Canadian Dollars [US$775,538.35 ]
bioasis Technologies Inc.
(4.08 million Canadian Dollars [US$3.29 million]
based in UNITED STATES
Sales were up sharply during the first
quarter of 2022 versus the previous year's first quarter.
During the first
quarter of 2022, sales at Antibe Therapeutics Inc totalled
an increase of 128.8%
from the C$1.19 million in sales at the company during the first quarter of 2021.
This was the biggest same quarter rise in sales at Antibe Therapeutics Inc in the previous 20 quarters.
There appears to be at least some degree of seasonality in the sales at Antibe Therapeutics Inc: during 4 of the previous 5
years, sales were highest during the first quarter.
The exception to this was during 2021, when the
fourth quarter was the best quarter, accounting for
30% of sales (during that same year, the
first quarter accounted for 12% of sales).
Antibe Therapeutics Inc reported sales of C$9.71 million (US$7.84 million)
March of 2021.
decrease of 2.7%
versus 2020, when the company's sales were C$9.99 million.